Abstract
Background: Female Taiwanese breast cancer patients are younger than their Western counterparts. This study examined the predictors of axillary lymph node metastases in Taiwanese women with T1 breast cancer.
Methods: Data from 394 Taiwanese women with T1 invasive breast carcinoma were retrospectively reviewed.
Results: The data contained 6 T1a, 51 T1b, and 337 T1c breast tumors. The patients’ ages ranged from 23 to 82 years (mean ± SD, 48.2 ± 11.4 years; median, 46.4 years). Axillary nodal metastases were present in 38.3% of the patients (16.7% in T1a, 35.3% in T1b, and 39.2% in T1c tumors). The patients with nodal metastases had significantly greater body weights and S-phase fractions than those without nodal metastases. Univariate analysis revealed that unfavorable pathology, lymphovascular invasion, S-phase fraction >7%, and nondiploid DNA ploidy were significantly associated with lymph node metastases. Lymphovascular invasion was the only significant variable as the independent predictor in the multiple logistic regression analysis. In the Cox proportional hazards regression analysis, axillary nodal status and lymphovascular invasion were significantly associated with survival.
Conclusions: Taiwanese women with small breast cancer displayed a relatively higher incidence of axillary lymph node metastases than Western women. Axillary lymph node dissection or sentinel lymph node biopsy should be conducted on Taiwanese patients with small invasive breast carcinomas, particularly when risk factors exist.
Similar content being viewed by others
REFERENCES
Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181–7.
Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Arch Surg 1996; 131: 301–8.
Harris JR, Lippman ME, Veronesi U, Willet W. Breast cancer. N Engl J Med 1992; 327: 473–80.
Mansour EG, Ravdin PM, Dressler L. Prognostic factors in early breast carcinoma. Cancer 1994; 7: 381–400.
Wold LE, Ingle JN, Pisansky TM, Johnson RE, Donohue JH. Prognostic factors for patients with carcinoma of the breast. Mayo Clin Proc 1995; 70: 678–79.
Mustafa IA, Cole B, Wanebo HJ, Bland KI, Chang HR. The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg 1997; 132: 384–91.
Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997; 79: 1918–22.
Abner AL, Collins L, Peiro G, et al. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Cancer 1998; 83: 2502–8.
Chadha M, Chabon AB, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis. Cancer 1994; 73: 350–3.
Shoup M, Malinzak L, Weisenberger J, Aranha GV. Predictors of axillary lymph node metastases in T1 breast carcinoma. Am Surg 1999; 65: 748–53.
Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 1994; 73: 664–7.
Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993; 11: 1536–44.
Maibenco DC, Weiss LK, Pawlish KS, Severson RK. Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer 1999; 85: 1530–6.
Saiz E, Toonkel R, Poppiti RJ, Robinson MJ. Infiltrating breast carcinoma smaller than 0.5 centimeters. Is lymph node dissection necessary? Cancer 1999; 85: 2206–11.
Port ER, Tan LK, Borgen PI, Van Zee KJ. Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma. Ann Surg Oncol 1998; 5: 23–7.
McGee JM, Youmans R, Clingan F, Malnar K, Bellefeuille C, Berry B. The value of axillary dissection in T1a breast cancer. Am J Surg 1996; 172: 501–4.
White RE, Vezeridis MP, Konstadoulakis A, Cole BF, Wanebo HJ. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 1996; 183: 575–82.
Sosa JA, Diener-West M, Gusev Y, et al. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol 1998; 5: 140–9.
Bland KI, Coburn MC. Wound care and complications of mastectomy. In: Bland KI, Copeland EM, eds. The Breast: Comprehensive Management of Benign and Malignant Diseases. Philadelphia: WB Saunders Co, 1998: 995–1002.
Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998; 339: 941–6.
Dowlatshahi K, Fan M, Anderson JM, Bloom KJ. Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol 2001; 8: 675–82.
Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594–606.
Cheng SH, Tsou M-F, Liu M-C, et al. Unique features of breast cancer in Taiwan. Breast Cancer Res Treat 2000; 63: 213–23.
Natarajan N, Nemoto D, Nemoto T, Mettlin C. Breast cancer survival among Orientals and whites living in the United States. J Surg Oncol 1988; 39: 206–9.
Hsu JL, Glaser SL, West DW. Racial/ethnic differences in breast cancer survival among San Francisco Bay Area women. J Natl Cancer Inst 2001; 89: 1311–2.
Hannequin P, Liehn JC, Delisle MJ. Multifactorial analysis of survival in thyroid cancer: pitfalls of applying the results of published studies to another population. Cancer 1986; 58: 1749–55.
Bosl GJ, Geller NL, Cirrincione C, et al. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 1983; 43: 3403–7.
Breast cancer staging. In: Fleming ID, Cooper JS, Henson DE, et al., eds. AJCC Cancer Staging Manual. Philadelphia: Lippincott-Raven, 1997: 171–80.
Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981; 152: 765–72.
Kiricuta CI, Tausch J, Math D. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992; 69: 2496–501.
Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 1992; 28A: 1415–8.
Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg 2000; 191: 1–6.
Kallioniemi OP, Blanco G, Alavaikko M, et al. Improving the prognostic value of DNS flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer. Cancer 1988; 62: 2183–90.
Meyer JS. Cell kinetics of breast and breast tumors. In: Donegan WL, Spratt JS, eds. Cancer of the Breast. Philadelphia: WB Saunders Co, 1995: 279–308.
Wenger CR, Beardslee S, Owens MA, et al. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 1993; 28: 9–20.
Ravdin PM, De Laurentiis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1994; 86: 1771–5.
Olivotto IA, Jackson JS, Mates D, et al. Prediction of axillary lymph node involvement of women with invasive breast carcinoma. Cancer 1998; 83: 948–55.
Chontos AJ, Maher DP, Ratzer ER, Fenoglio ME. Axillary lymph node dissection: is it required in T1a breast cancer? J Am Coll Surg 1997; 184: 493–8.
Seidman JD, Schnaper LA, Aisner SC. Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastases. Cancer 1995; 75: 65–71.
Yang WT, Lam WW, Cheung H, Suen M, King WW, Metreweli C. Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer. J Ultrasound Med 1997; 16: 791–7.
Tresserra F, Feu J, Grases PJ, Navarro B, Alegret X, Fernandez-Cid A. Assessment of breast cancer size: sonographic and pathologic correlation. J Clin Ultrasound 1999; 27: 485–91.
Finlayson CA, MacDermott TA. Ultrasound can estimate the pathologic size of infiltrating ductal carcinoma. Arch Surg 2000; 135: 158–9.
Lin SS, Clarke CA, Prehn AW, Glaser SL, West DW, O’Malley CD. Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer 2002; 94: 1175–82.
Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003; 163: 49–56.
Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85: 1819–27.
Deapen D, Liu L, Perkins C, Bernstein L, Ross RK. Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer 2002; 99: 747–50.
Chao T-C, Lo Y-F, Chen S-C, Chen M-F. Prospective sonographic study of 3093 breast tumors. J Ultrasound Med 1999; 18: 363–70.
Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Breast carcinoma in women 35 years or younger. Ann Surg 1985; 119: 133–42.
Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000; 92: 550–6.
Lyman GH, Lyman S, Balducci L, et al. Age and the risk of breast cancer recurrence. Cancer Control 1996; 3: 421–7.
Mann GB, Port ER, Rizza C, Tan LK, Borgen PI, Van Zee KJ. Six-year follow-up of patients with microinvasive, T1a, and T1b breast carcinoma. Ann Surg Oncol 1999; 6: 591–8.
Mustafa IA, Cole B, Wanebo HJ, Bland KI, Chang HR. Prognostic analysis of survival in small breast cancers. J Am Coll Surg 1998; 186: 562–9.
Velanovich V. Axillary lymph node dissection for breast cancer: a decision analysis of T1 lesions. Ann Surg Oncol 1998; 5: 131–9.
Pandelidis SM, Peters K, Walusimbi MS, et al. The role of axillary dissection in mammographically detected carcinoma. J Am Coll Surg 1997; 184: 341–5.
Ruffin WK, Stacey-Clear A, Younger J, Hoover HC Jr. Rationale for routine axillary dissection in carcinoma of the breast. J Am Coll Surg 1995; 180: 245–51.
Giuliano A, Barth A, Spivack B, Beitsch PD, Evans SW. Incidence and predictors of axillary metastases in T1 carcinoma of the breast. J Am Coll Surg 1996; 183: 185–9.
Shetty M, Reiman H Jr. Tumor size and axillary metastasis. A correlative occurrence in 1244 cases of breast cancer between 1980 and 1995. Eur J Surg Oncol 1997; 23: 139–41.
Port RE, Tan LK, Borgen PI, Van Zee KJ. Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma. Ann Surg Oncol 1998; 5: 23–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chao, TC., Chen, MF., Wang, CS. et al. Small Invasive Breast Carcinomas in Taiwanese Women. Ann Surg Oncol 10, 740–747 (2003). https://doi.org/10.1245/ASO.2003.01.007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2003.01.007